Guardant Health (GH) Revenue & Revenue Breakdown
Guardant Health Revenue Highlights
Latest Revenue (Y)
$563.95M
Latest Revenue (Q)
$177.24M
Main Geography (Y)
UNITED STATES
Guardant Health Revenue by Period
Guardant Health Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $563.95M | 25.45% |
| 2022-12-31 | $449.54M | 20.31% |
| 2021-12-31 | $373.65M | 30.32% |
| 2020-12-31 | $286.73M | 33.75% |
| 2019-12-31 | $214.38M | 136.52% |
| 2018-12-31 | $90.64M | 81.85% |
| 2017-12-31 | $49.84M | 97.40% |
| 2016-12-31 | $25.25M | - |
Guardant Health generated $563.95M in revenue during NA 2023, up 25.45% compared to the previous quarter, and up 622.19% compared to the same period a year ago.
Guardant Health Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $177.24M | 5.19% |
| 2024-03-31 | $168.49M | 8.67% |
| 2023-12-31 | $155.05M | 8.41% |
| 2023-09-30 | $143.03M | 4.29% |
| 2023-06-30 | $137.15M | 6.55% |
| 2023-03-31 | $128.71M | 1.44% |
| 2022-12-31 | $126.89M | 8.08% |
| 2022-09-30 | $117.40M | 7.57% |
| 2022-06-30 | $109.14M | 13.57% |
| 2022-03-31 | $96.10M | -11.11% |
| 2021-12-31 | $108.11M | 14.06% |
| 2021-09-30 | $94.78M | 2.91% |
| 2021-06-30 | $92.10M | 17.08% |
| 2021-03-31 | $78.67M | 0.45% |
| 2020-12-31 | $78.32M | 5.02% |
| 2020-09-30 | $74.57M | 12.41% |
| 2020-06-30 | $66.33M | -1.74% |
| 2020-03-31 | $67.51M | 7.33% |
| 2019-12-31 | $62.90M | 3.37% |
| 2019-09-30 | $60.85M | 12.73% |
| 2019-06-30 | $53.98M | 47.25% |
| 2019-03-31 | $36.66M | 11.50% |
| 2018-12-31 | $32.87M | 51.54% |
| 2018-09-30 | $21.69M | 11.92% |
| 2018-06-30 | $19.38M | 16.12% |
| 2018-03-31 | $16.69M | -16.55% |
| 2017-12-31 | $20.00M | 79.68% |
| 2017-09-30 | $11.13M | 9.18% |
| 2017-06-30 | $10.20M | 9.00% |
| 2017-03-31 | $9.35M | - |
Guardant Health generated $177.24M in revenue during Q2 2024, up 5.19% compared to the previous quarter, and up 137.70% compared to the same period a year ago.
Guardant Health Revenue Breakdown
Guardant Health Revenue Breakdown by Product
Quarterly Revenue by Product
| Product/Service | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Dec 18 | Sep 18 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-US | $7.89M | $9.80M | $9.08M | $6.31M | $8.31M | $5.23M | $6.14M | $4.36M | $4.23M | $6.37M | $5.31M | $8.96M | $4.91M | $2.90M | $3.50M | $6.17M | $4.98M | $5.41M | $9.11M | $3.76M |
| UNITED STATES | $129.26M | $118.91M | $117.81M | $111.10M | $100.84M | $90.87M | $101.97M | $90.42M | $87.87M | $72.30M | $73.01M | $65.61M | $61.42M | $64.61M | $59.40M | $54.67M | $49.00M | $31.25M | $51.69M | $17.93M |
Guardant Health's latest quarterly revenue breakdown by segment (product or service), as of Jun 23: UNITED STATES (94.25%), and Non-US (5.75%).
Guardant Health Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| UNITED STATES | $526.52M | $420.62M | $352.56M | $264.66M | $194.31M |
| Non-US | $37.42M | $28.92M | $21.09M | $22.07M | $20.06M |
Guardant Health's latest annual revenue breakdown by geography, as of Dec 23: UNITED STATES (93.36%), and Non-US (6.64%).
Quarterly Revenue by Country
| Country | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| UNITED STATES | $157.35M | $142.62M | $135.74M | $129.26M | $118.91M | $117.81M | $111.10M | $100.84M | $90.87M | $101.97M | $90.42M | $87.87M | $72.30M | $73.01M | $65.61M | $61.42M | $64.61M | $59.40M | $54.67M | $49.00M |
| Non-US | $11.14M | $12.44M | $7.29M | $7.89M | $9.80M | $9.08M | $6.31M | $8.31M | $5.23M | $6.14M | $4.36M | $4.23M | $6.37M | $5.31M | $8.96M | $4.91M | $2.90M | $3.50M | $6.17M | $4.98M |
Guardant Health's latest quarterly revenue breakdown by geography, as of Mar 24: UNITED STATES (93.39%), and Non-US (6.61%).
Guardant Health Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| TMO | Thermo Fisher Scientific | $42.86B | $10.54B |
| DHR | Danaher | $14.03B | $3.43B |
| A | Agilent | $6.83B | $1.58B |
| ILMN | Illumina | $4.50B | $1.08B |
| CRL | Charles River Laboratories | $4.13B | $1.03B |
| NTRA | Natera | $1.08B | $413.35M |
| MYGN | Myriad Genetics | $678.40M | $191.90M |
| GH | Guardant Health | $563.95M | $177.24M |
| CDNA | CareDx | $280.32M | $92.27M |
| TWST | Twist Bioscience | $245.11M | $81.46M |
| CSTL | Castle Biosciences | $219.79M | $87.00M |
| PSNL | Personalis | $73.48M | $19.52M |
GH Revenue FAQ
What is Guardant Health’s yearly revenue?
Guardant Health's yearly revenue for 2023 was $563.95M, representing an increase of 25.45% compared to 2022. The company's yearly revenue for 2022 was $449.54M, representing an increase of 20.31% compared to 2021. GH's yearly revenue for 2021 was $373.65M, representing an increase of 30.32% compared to 2020.
What is Guardant Health’s quarterly revenue?
Guardant Health's quarterly revenue for Q2 2024 was $177.24M, a 5.19% increase from the previous quarter (Q1 2024), and a 29.23% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $168.49M, a 8.67% increase from the previous quarter (Q4 2023), and a 30.90% increase year-over-year (Q1 2023). GH's quarterly revenue for Q4 2023 was $155.05M, a 8.41% increase from the previous quarter (Q3 2023), and a 22.19% increase year-over-year (Q4 2022).
What is Guardant Health’s revenue growth rate?
Guardant Health's revenue growth rate for the last 3 years (2021-2023) was 50.93%, and for the last 5 years (2019-2023) was 163.07%.